FDA Issues Warning Letter to Winder Laboratories
January 14, 2026
January 14, 2026
WASHINGTON, Jan. 14 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Winder Laboratories LLC from the Center for Drug Evaluation and Research:
* * *
Recipient: Steven F. Pressman, CEO, Winder Laboratories, LLC, 716 Patrick Industrial Lane, Winder, GA 30680, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning Letter 320-26-36
* * *
Recipient: Steven F. Pressman, CEO, Winder Laboratories, LLC, 716 Patrick Industrial Lane, Winder, GA 30680, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
Warning Letter 320-26-36
